OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 5.9 EUR -4.07% Market Closed
Market Cap: 129.4m EUR

OSE Immunotherapeutics SA
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OSE Immunotherapeutics SA
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
OSE Immunotherapeutics SA
PAR:OSE
Non-Reccuring Items
-€80k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Non-Reccuring Items
-€445k
CAGR 3-Years
57%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Non-Reccuring Items
€2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Non-Reccuring Items
€90k
CAGR 3-Years
-86%
CAGR 5-Years
146%
CAGR 10-Years
N/A
Inventiva SA
PAR:IVA
Non-Reccuring Items
€160k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Non-Reccuring Items
-€2.7m
CAGR 3-Years
N/A
CAGR 5-Years
-128%
CAGR 10-Years
-33%

OSE Immunotherapeutics SA
Glance View

Market Cap
128.4m EUR
Industry
Biotechnology

OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

OSE Intrinsic Value
7.94 EUR
Undervaluation 26%
Intrinsic Value
Price

See Also

What is OSE Immunotherapeutics SA's Non-Reccuring Items?
Non-Reccuring Items
-80k EUR

Based on the financial report for Jun 30, 2024, OSE Immunotherapeutics SA's Non-Reccuring Items amounts to -80k EUR.

Back to Top